BPG is committed to discovery and dissemination of knowledge
Editorial
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Hepatol. Sep 27, 2026; 18(9): 117720
Published online Sep 27, 2026. doi: 10.4254/wjh.117720
From algorithm to bedside: Navigating the promise and perils of implementing machine learning for variceal bleeding mortality prediction
Amira A A Othman
Amira A A Othman, Department of Internal Medicine, Suez University, Suez 43511, Suez, Egypt
Author contributions: Othman AAA conceptualized the editorial theme, reviewed the relevant literature, and wrote the manuscript.
AI contribution statement: Grammarly was used for English grammar only. The writing of this manuscript did not utilize any other artificial intelligence.
Conflict-of-interest statement: The author declares that there are no conflicts of interest related to this work.
Corresponding author: Amira A A Othman, MD, PhD, Lecturer, Principal Investigator, Department of Internal Medicine, Suez University, Cairo-Suez Road, Suez 43511, Suez, Egypt. amira.othman@med.suezuni.edu.eg
Received: December 15, 2025
Revised: February 16, 2026
Accepted: March 25, 2026
Published online: September 27, 2026
Processing time: 277 Days and 6.9 Hours
Core Tip

Core Tip: Machine learning is transitioning from theoretical promise to practical implementation within hepatology, particularly in high-risk conditions such as acute esophageal variceal bleeding. The study by Rech et al distinguishes itself by combining high-performing mortality prediction with prospective validation and real-world deployment as an online calculator. This editorial highlights why such efforts represent an important step toward bridging the persistent gap between algorithm development and clinical adoption. Yet we also explore the remaining challenges-model interpretability, ethical complexities surrounding race-based predictors, workflow integration, model drift, and the need for multicenter external validation. Understanding these dimensions is crucial for translating artificial intelligence into safer, more equitable, and genuinely impactful tools at the bedside.

Write to the Help Desk